AI assistant
Sending…
BOSTON SCIENTIFIC CORP — Director's Dealing 2021
Apr 1, 2021
29821_dirs_2021-04-01_5b1f1b80-0028-4b71-b285-40dce7c82f9d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2021-03-30
Reporting Person: BOSTON SCIENTIFIC CORP (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-30 | Common Stock | S | 1350000.0000 | $40.8000 | Disposed | 4638106.0000 | Direct |
Footnotes
F1: These shares of the Issuer's common stock were sold in a block order at a price of $40.80.
More from BOSTON SCIENTIFIC CORP
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 18
Capital/Financing Update
2026
May 18
Share Issue/Capital Change
2026
May 8
Major Shareholding Notification
2026
May 6
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Interim / Quarterly Report
2026
May 1
Major Shareholding Notification
2026
Apr 29
Earnings Release
2026
Apr 22
Regulatory Filings
2026
Apr 2